21st Annual dbAccess Global Consumer Conference 2024
Logotype for Haleon plc

Haleon (HLN) 21st Annual dbAccess Global Consumer Conference 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for Haleon plc

21st Annual dbAccess Global Consumer Conference 2024 summary

1 Feb, 2026

Regional overview and growth strategy

  • EMEA and LATAM represent 44% of the global population and account for 40% of company revenues, with GBP 4.5 billion in annual sales across 100+ markets and a workforce of 12,000 employees.

  • The region is organized into seven business units, supported by 13 integrated factories, with LATAM fully supplied internally.

  • Growth is driven by a balanced portfolio: one-third of revenues from oral health, nearly a quarter from pain relief, and strong positions in respiratory health and VMS.

  • Power brands account for 68% of regional revenue, complemented by local growth brands with strong heritage in specific markets.

  • Organic revenue growth in EMEA & LATAM reached 12.6% in 2023, supported by net revenue management and operational efficiencies.

Brand and category performance

  • Leading positions in pain relief (Panadol, Voltaren), oral health (Sensodyne, Parodontax), and VMS (Centrum), with double-digit growth in key brands.

  • Parodontax achieved double-digit growth over three years, with 20% growth in Q1, driven by expert engagement and expanded access.

  • Panadol delivered double-digit growth, offering solutions across all life stages and reinforcing trust during the COVID period.

  • Centrum expanded in emerging markets through geo-expansion, increased activation, and tailored products for low-income consumers, achieving market leadership in Brazil and launches in Egypt.

  • Local brands like Be-Total (Italy) and Grand-Pa (South Africa) maintain strong consumer loyalty and market leadership.

Go-to-market and channel strategy

  • Pharmacy is the dominant channel, accounting for over 60% of revenues and nearly double the size of the next competitor.

  • Mass market represents over 30% of revenues, with top-tier supplier status in more than 60% of markets.

  • Digital commerce is under 10% of revenues, limited by regulatory and digital maturity differences across countries.

  • Shopper Science Lab and advanced analytics optimize category growth and shopper experience in both pharmacy and mass market channels.

  • Pharmacist engagement and education are key, with 80% of pharmacist recommendations leading to purchases.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more